Stephen Tulipano, CFO at Aldeyra Therapeutics, holds 20.75K shares in Stoke Therapeutics (Ticker: STOK), holds 8.56K shares in Aldeyra Therapeutics (Ticker: ALDX).

See the Hottest Stocks Based on Insider Trading >

Stephen Tulipano
Aldeyra Therapeutics (ALDX)
CFO

Ranked #37,981 out of 98,624 Corporate Insiders

Profitable Transactions

1 out of 2 Profitable Transactions

Average Return

+24.00%

Average return per transaction

Time Frame

1 Year

Compare to

No Benchmark

How are Insiders Ranked?

Insider Holdings

88.44%

STOK

11.56%

ALDX

A breakdown of Stephen Tulipano's holdings

See the Top Stocks by Insiders

Insider Roles

Stoke Therapeutics
(STOK)

CFO

Aldeyra Therapeutics
(ALDX)

CFO

Roles that Stephen Tulipano holds in companies

See the Top Corporate Insiders

Most Profitable Insider Trade

Stock:

Aldeyra Therapeutics
(ALDX)

Rating:Informative Buy

Date:Feb 21, 2017 - Feb 21, 2018

Return:+48.50%

The most profitable trade made by Stephen Tulipano

See the Latest Stocks Traded by Insiders

Stephen Tulipano's Trading History

ALDX

Aldeyra Therapeutics

Mar 08, 2018

CFO

Uninformative Buy

8.20K

$33.65K

STOK

Stoke Therapeutics

Mar 19, 2024

CFO

Uninformative Buy

25.07K

$257.46K

List of latest transactions for each holding click on a transaction to see Stephen Tulipano's performance on stock

See All Insider Trading from Today

Stephen Tulipano insider profile FAQ

What is the percentage of profitable transactions made by Stephen Tulipano?

The percentage of profitable transactions made by Stephen Tulipano is 50%.

What is the average return per transaction made by Stephen Tulipano?

The average return per transaction made by Stephen Tulipano is 24.00%.

What stocks does Stephen Tulipano hold?

Stephen Tulipano holds: ALDX, STOK stocks.

What was Stephen Tulipano’s latest transaction?

Stephen Tulipano latest transaction was an Uninformative Buy of $25.07K.

What was Stephen Tulipano's most profitable transaction?

Stephen Tulipano’s most profitable transaction was an Informative Buy of ALDX stock on February 21, 2017. The return on the trade was 48.50%.

What is Stephen Tulipano's role in Aldeyra Therapeutics?

Stephen Tulipano's role in Aldeyra Therapeutics is CFO.

How can I follow the stock ratings of top corporate insiders?

Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

Stephen Tulipano Insider Profile

Stephen Tulipano Aldeyra Therapeutics (ALDX)CFO